Drug Patents owned by Btcp Pharma

1. List of Lazanda drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9814705 BTCP PHARMA Intranasal spray device containing pharmaceutical composition
Jan, 2024

(11 months from now)

US9078814 BTCP PHARMA Intranasal spray device containing pharmaceutical composition
Jan, 2024

(11 months from now)

US8889176 BTCP PHARMA Method of managing or treating pain
Jan, 2024

(11 months from now)

US8216604 BTCP PHARMA Method of managing or treating pain
Oct, 2024

(1 year, 8 months from now)

US9731869 BTCP PHARMA Container
Jan, 2032

(8 years from now)

Drugs and Companies using FENTANYL CITRATE ingredient

Market Authorisation Date: 30 June, 2011

Treatment: Management of breakthrough pain in patients with cancer

Dosage: SPRAY, METERED;NASAL

More Information on Dosage

2. List of Subsys drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10610523 BTCP PHARMA Sublingual fentanyl spray
Jan, 2027

(3 years from now)

US8835459 BTCP PHARMA Sublingual fentanyl spray
Jan, 2027

(3 years from now)

US10016403 BTCP PHARMA Sublingual fentanyl spray
Jan, 2027

(3 years from now)

US9241935 BTCP PHARMA Sublingual fentanyl spray
Jan, 2027

(3 years from now)

US8835460 BTCP PHARMA Sublingual fentanyl spray and methods of treating pain
Jan, 2027

(3 years from now)

US9642797 BTCP PHARMA Sublingual fentanyl spray and methods of use to treat pain
Jan, 2027

(3 years from now)

US9289387 BTCP PHARMA Method of treating pain by administering sublingual fentanyl spray
Jan, 2027

(3 years from now)

US9642844 BTCP PHARMA Sublingual fentanyl spray
Jan, 2027

(3 years from now)

US8486973 BTCP PHARMA Sublingual fentanyl spray
Apr, 2030

(7 years from now)

US8486972 BTCP PHARMA Sublingual fentanyl spray
Apr, 2030

(7 years from now)

Drugs and Companies using FENTANYL ingredient

Market Authorisation Date: 04 January, 2012

Treatment: Treatment of pain

Dosage: SPRAY;SUBLINGUAL

How can I launch a generic of SUBSYS before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in